Stockholm - Delayed Quote SEK
Biosergen AB (BIOSGN.ST)
At close: November 6 at 5:29 PM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-36,878.0000
-32,756.0000
-29,441.0000
-37,749.0000
-4,584.0000
Financing Cash Flow
31,472.0000
5,297.0000
37,118.0000
58,825.0000
--
End Cash Position
10,451.0000
1,883.0000
29,342.0000
21,665.0000
589.0000
Issuance of Capital Stock
31,472.0000
5,297.0000
37,118.0000
58,825.0000
--
Free Cash Flow
-36,878.0000
-32,756.0000
-29,441.0000
-37,749.0000
-4,584.0000
12/31/2020 - 6/24/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
DIABIO.ST Diagonal Bio AB (publ)
0.0319
-4.20%
ATORX.ST Alligator Bioscience AB (publ)
0.6620
-8.06%
PILA.ST Pila Pharma AB (publ)
4.6700
-2.71%
LIDDS.ST LIDDS AB (publ)
0.1010
-36.87%
CHOSA.ST CHOSA Oncology AB
0.7000
-1.41%
APTA.ST Aptahem AB (publ)
1.6000
-3.03%
0H22.IL BioInvent International AB (publ)
45.10
+0.84%
ZICC.ST Ziccum AB (publ)
2.3500
-0.84%
NANECH.ST NanoEcho AB
0.2300
+0.88%
PCIB.OL PCI Biotech Holding ASA
1.6500
+0.86%